Loading viewer...
earnings
Format: PDF earnings
Embracer Group's Q3 2023 investor presentation reports continued strong earnings growth with sales of SEK 8,458 million, up 12 percent year-over-year. The company achieved an EBITA margin of 17.6 percent and demonstrated robust operating cash flow of SEK 1,608 million, reflecting strong operational performance across its business areas.
presentation
earnings
20 Pages
Nexans
Relmada Therapeutics 2022 Earnings Call REL-1017 Results
earningsearnings
13 Pages
Relmada Therapeutics, Inc.
Domtar Q3 2016 Earnings Call October
earningsearnings
18 Pages
Domtar Corporation